Last updated: May 18, 2026
Very common side effects (>10% of users)
- Nausea — 40-45% during dose escalation, improves over 4-8 weeks
- Vomiting — 20-25%, especially in first 2-4 weeks
- Diarrhea — 20-30%
- Constipation — 15-25%
- Decreased appetite — 50% or more (often considered therapeutic effect)
- Abdominal pain — 15-20%
- Headache — 10-15%
- Fatigue — 10-15%
Common side effects (1-10%)
- Dyspepsia, gastroesophageal reflux
- Eructation (belching)
- Dizziness
- Dysgeusia (altered taste)
- Injection-site reactions (mild)
- Hypoglycemia (when combined with insulin or sulfonylureas)
Less common but important (0.1-1%)
- Acute pancreatitis — rare but serious. Symptoms: severe abdominal pain radiating to back, persistent vomiting. Discontinue immediately if suspected.
- Cholelithiasis (gallstones) and cholecystitis
- Acute kidney injury — usually associated with severe dehydration from vomiting
- Retinopathy progression — in T2D patients with pre-existing retinopathy
- Hypersensitivity reactions
Rare but serious
- Severe gastroparesis — persistent significant gastric emptying delay, occasionally not resolving after discontinuation
- Intestinal obstruction
- Suicidal ideation — investigated by FDA 2023-2024; conclusions remain unsettled but causal relationship not established
Boxed warning: thyroid C-cell tumors
Semaglutide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors in rodents at clinically relevant exposures. Human relevance is unknown. The FDA boxed warning contraindicates semaglutide in:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia syndrome type 2 (MEN2)
How to manage GI side effects
- Slow titration — extend each dose step if needed
- Eat smaller, frequent meals
- Avoid high-fat, spicy, or strongly-flavored foods initially
- Stay well-hydrated
- Anti-nausea medication (ondansetron) for short-term use during escalation
- If symptoms persist >8 weeks at a dose, consider dose reduction
Will the nausea ever go away?<br />
For most users, nausea peaks during dose escalation and resolves within 4-8 weeks at each stable dose level.
Should I stop semaglutide if I get pancreatitis symptoms?<br />
Yes — severe abdominal pain radiating to the back, with or without vomiting, requires immediate medical evaluation. Discontinue semaglutide pending evaluation.
Does semaglutide cause thyroid cancer in humans?<br />
The rodent finding has not been observed in human clinical or post-marketing data. The boxed warning is precautionary. Contraindicated in personal/family MTC or MEN2.
What are the most serious risks?<br />
Acute pancreatitis, gallbladder disease, severe gastroparesis. All are rare but can be serious. Patient education on warning signs is important.